Cite
HARVARD Citation
Othman, T. et al. (2020). Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy. Leukemia & lymphoma. 61 (14), pp. 3532-3533. [Online].